(Q51149673)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24691745%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

title

Non-alcoholic fatty liver disease and risk of in-stent restenosis after bare metal stenting in native coronary arteries (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24691745%20AND%20SRC:MED&resulttype=core&format=json

metabolic dysfunction–associated steatotic liver disease

12 March 2020

main subject

1 reference

non-alcoholic fatty liver

inferred from title

1 reference

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24691745%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Keqing Shi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24691745%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Wen-Yue Liu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24691745%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

author name string

Fa-Ling Wu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24691745%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Chen-Chen Zhao

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24691745%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Chang-Xi Chen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24691745%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Yao-Yao Xie

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24691745%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Sheng-Jie Wu

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24691745%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Xian-Feng Lin

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24691745%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Yong-Ping Chen

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24691745%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Danny Ka-Ho Wong

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24691745%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Man-Fung Yuen

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24691745%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

publication date

2 April 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24691745%20AND%20SRC:MED&resulttype=core&format=json

Molecular Biology Reports

12 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24691745%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

volume

41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24691745%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24691745%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

page(s)

4713-4720

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24691745%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11033-014-3342-z

12 March 2020

exact match

0 references

cites work

Epidemiology of non-alcoholic fatty liver disease in China.

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3342-Z

Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3342-Z

Quality of life in adults with nonalcoholic fatty liver disease: baseline data from the nonalcoholic steatohepatitis clinical research network

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3342-Z

Review: The role of insulin resistance in nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3342-Z

Influence of non-alcoholic fatty liver disease on the development of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3342-Z

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3342-Z

Non-alcoholic fatty liver disease and increased risk of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3342-Z

Increased risk of cardiovascular disease and chronic kidney disease in NAFLD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3342-Z

Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3342-Z

Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3342-Z

Diagnostic accuracy of 64 multislice CT angiography in the assessment of coronary in-stent restenosis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3342-Z

Role of inflammation and insulin resistance in endothelial progenitor cell dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3342-Z

Serum levels of bilirubin as an independent predictor of coronary in-stent restenosis: a new look at an old molecule.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3342-Z

Diagnosis and evaluation of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3342-Z

A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3342-Z

Predictors of angiographic restenosis after coronary intervention in patients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3342-Z

The role of muscle insulin resistance in the pathogenesis of atherogenic dyslipidemia and nonalcoholic fatty liver disease associated with the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3342-Z

The emerging role of endocrine disruptors in pathogenesis of insulin resistance: a concept implicating nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3342-Z

Preventative effects of rosiglitazone on restenosis after coronary stent implantation in patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3342-Z

Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3342-Z

Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3342-Z

Effects of statins on restenosis after coronary stent implantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3342-Z

Obesity and clinical restenosis after coronary stent placement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3342-Z

Gender and restenosis after coronary artery stenting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3342-Z

Rapid estrogen receptor signaling is essential for the protective effects of estrogen against vascular injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3342-Z

Insights into the effect of nitric oxide and its metabolites nitrite and nitrate at inhibiting neointimal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3342-Z

Ultrasonography as a non-invasive tool for detection of nonalcoholic fatty liver disease in overweight/obese Egyptian children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3342-Z

Acute and chronic tissue response to coronary stent implantation: pathologic findings in human specimen

21 January 2018

1 reference

12 December 2020

Estradiol, acting through estrogen receptor alpha, restores dimethylarginine dimethylaminohydrolase activity and nitric oxide production in oxLDL-treated human arterial endothelial cells

1 reference

12 December 2020

Risk of cardiovascular disease and chronic kidney disease in diabetic patients with non-alcoholic fatty liver disease: just a coincidence?

1 reference

12 December 2020

Nonalcoholic fatty liver disease is associated with atherosclerosis in middle-aged and elderly Chinese

1 reference

12 December 2020